Alejandro Falcón

1.1k citations
28 papers · 719 · 2 hit papers · h-index 10

Impact in

  • Oncology top 10%
    • Colorectal Cancer Treatments and Studies
    • Pancreatic and Hepatic Oncology Research
    • Cancer Immunotherapy and Biomarkers
    • Lung Cancer Treatments and Mutations
    • Advanced Breast Cancer Therapies

Papers in

    • HER2/EGFR in Cancer Research 4
    • Cancer Immunotherapy and Biomarkers 3
    • Cancer Treatment and Pharmacology 2
    • Lung Cancer Treatments and Mutations 4
    • Advanced Breast Cancer Therapies 2

Alejandro Falcón

24 papers receiving 702 citations

Alejandro Falcón's Hit Papers

Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation 2023 · 247 citations
2470+1+2Years since publication50100150200

Peers

Alejandro Falcón
Comparison fields: 5 of 47
  • Oncology 232
  • Pulmonary and Respiratory Medicine 191
  • Cancer Research 82
  • Molecular Biology 174
  • Genetics 22
Replace Long Bai with:
Long Bai China
Mian Xie China
Allen D. Saliganan United States
Chenkui Miao China
Xiufeng Hu China
Young Bae Kim South Korea
Pan Tong United States
Yongfeng Yu China
Hai Qin China
Alejandro Falcón relative to Long Bai China Long Bai's profile →
Citations per field
00.5×2×4×6×8.4×
Long Bai · 1×
Citations per year

Countries citing papers authored by Alejandro Falcón

Since Specialization
Citations

This map shows the geographic impact of Alejandro Falcón's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Alejandro Falcón with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Alejandro Falcón more than expected).

Fields of papers citing papers by Alejandro Falcón

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Alejandro Falcón. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Alejandro Falcón. The network helps show where Alejandro Falcón may publish in the future.

Co-authors

The 25 scholars most cited alongside Alejandro Falcón, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Alejandro Falcón Line = papers co-authored together Alejandro Falcón links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 28 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Single-Agent Divarasib (GDC-6036) in Solid Tumors with a KRAS G12C Mutation
Hit paper breakdown →
2023247
2
Erdafitinib in patients with advanced solid tumours with FGFR alterations (RAGNAR): an international, single-arm, phase 2 study
Hit paper breakdown →
2023148
3 2023102
4 202350
5 201937
6 201827
7 202423
8 202520
9 202219
10 201912
11 20245
12 20234
13 20244
14 20193
15 20193
16 20253
17 20152
18 20212
19 20232
20 20242

About Alejandro Falcón

Alejandro Falcón is a scholar working on Oncology, Pulmonary and Respiratory Medicine, Cancer Research, Molecular Biology and Surgery, having authored 28 papers that have together received 719 indexed citations. Recurring topics across this work include Lung Cancer Treatments and Mutations (4 papers), Breast Cancer Treatment Studies (4 papers), HER2/EGFR in Cancer Research (4 papers), Cancer Immunotherapy and Biomarkers (3 papers), Cancer therapeutics and mechanisms (3 papers), Advanced Breast Cancer Therapies (2 papers), Cancer Treatment and Pharmacology (2 papers) and Bladder and Urothelial Cancer Treatments (2 papers). The work is most often cited by research in Oncology (232 citations), Pulmonary and Respiratory Medicine (191 citations), Cancer Research (82 citations), Molecular Biology (174 citations) and Genetics (22 citations). Alejandro Falcón has collaborated with scholars based in Spain, United States and South Korea. Frequent co-authors include Manuel Ruíz‐Borrego, Sonia Molina‐Pinelo, María Ángeles Castilla, Javier Salvador Bofill, Marta Benavent, Eva Carrasco, Marta Gil-Martín, Nuria Ribelles, Federico Rojo and Alberto Ocaña. Their work appears in journals such as Journal of Thoracic Oncology, Clinical & Translational Oncology, Frontiers in Oncology, Clinical Cancer Research and Cancers.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact